TRACK: Newsletter - Issue 03 - 11 May 2021

 

 

Issue 3   |  11 May 2021 

 

Study Overview
The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.

 

Participant Recruitment

 

Meet the Team

 

Progress Updates


To remain up to date on site status, visit; 
https://www.tracktrial.org/participating-sites/